Navigation Links
AACR to honor leading researchers at breast cancer symposium
Date:10/12/2010

PHILADELPHIA The 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers during its meeting, which will be held Dec. 8-12 in the Henry B. Gonzales Convention Center, San Antonio, Texas. Klaus Pantel, M.D., Ph.D., is the recipient of the 2010 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure. Alan Ashworth, Ph.D., will give the 2010 AACR Distinguished Lectureship in Breast Cancer Research.

2010 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure

Klaus Pantel, M.D., Ph.D., professor at the Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, will receive the 2010 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure.

This award recognizes an investigator under 50 years of age whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment or prevention of breast cancer.

Pantel is honored for his pioneering and original work on the detection of minimal residual disease and for using this information to provide improved care for breast cancer patients. His research breaks new ground toward a better understanding of the metastatic process and patient treatment.

Pantel will deliver his award lecture entitled, "Cancer Micrometastasis and Circulating Tumor Cells," on Thursday, Dec. 9, 2010, from 11:30 a.m. - 12:00 p.m. CT.

2010 AACR Distinguished Lectureship in Breast Cancer Research

Alan Ashworth Ph.D., director of the Breakthrough Research Centre at the Institute of Cancer Research, will present the 2010 AACR Distinguished Lectureship in Breast Cancer Research.

Supported by Bristol-Myers Squibb, this AACR lectureship has been established to recognize outstanding science that has inspired or has the potential to inspire new perspectives on the etiology, diagnosis, treatment or prevention of breast cancer. The lectureship is selected by the San Antonio Breast Cancer Symposium Program Committee.

Ashworth is recognized for his contribution to the discovery of the BRCA2 gene and his team's identification of the synthetic lethality between BRCA mutations and PARP inhibitors. The high sensitivity of BRCA1 or BRCA2 mutant cells to PARP inhibitors forms the rationale behind clinical trials that are now assessing the potential of these agents.

Ashworth will deliver his lecture entitled, "Synthetic Lethal Approaches to Cancer Therapy" on Friday, Dec. 10, 2010, from 11:30 a.m. - 12:00 p.m. CT.


'/>"/>

Contact: Michele Leiberman
michele.leiberman@aacr.org
267-646-0622
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Laser Spine Institute Honored at the Gridiron Greats Night of Champions
2. Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona
3. Lakeside Medical Organization, Dr. Richard Merkin, CEO, Honored by United Chambers of Commerce
4. US Oncology Honored by Texas Governor Perrys Office with Inaugural Governors Business Hall of Fame Award
5. Elizabeth Colston, MD, PhD, of CONNEXION Healthcare, Honored as Rising Star by Healthcare Businesswomens Association
6. Siemens Awards for Advanced Placement Honor Top U.S. Science and Math Students and Teachers
7. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
8. AADR presents honorary membership to Senator Tom Harkin
9. Connecticut Governor Jodi Rell Honors Mountainside Addiction Treatment Center for its Twelve Years of Operating in Connecticut
10. Amerigroup CEO James Carlson Honored at Crystal Ball for a Cure Annual Gala
11. CareTech Solutions Honors Five Hospitals with Rising Star Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates Insurance & Financial, serving ... program, has teamed up with Citizens Opposed to Domestic Abuse in support of its ... support all those victimized by the fear of violence in their own homes, donations ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... enrichment program serving the greater Venice, FL area, has initiated a fundraiser for ... a car accident just four days after Christmas. To support this beautiful child ...
(Date:2/8/2016)... ... February 08, 2016 , ... T.E.N., ... that nominations will be accepted February 8, 2016 through May 8, 2016 ... include the Information Security Executive® of the Year, which recognizes executives who ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Discover the ... visit over 1,400 booths and 700 companies. Attendees also get to see the ... Colorado Garden & Home Show , at the Colorado Convention Center - 700 ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- Vestagen Technical Textiles, Inc., a medical technology company ... other demanding applications, today announced it has named ... Dale Pfost , PhD, who was serving as interim ... Vestagen,s Board of Directors. ® , the ... that combines fluid repellent, antimicrobial and breathability properties. VESTEX ...
(Date:2/8/2016)... Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... injectable drug delivery systems, today announced that it will release ... December 31, 2015 after market close on February 9, 2016. ... call to discuss these financial results.    About ... --> About Unilife Corporation ...
(Date:2/8/2016)...  Astellas Pharma Inc. President and Chief Executive Officer ... Robinson as president, Americas Operations, for Astellas US LLC, ... South America , effective April 1, 2016.  Robinson ... organization in the United States -- ... Yoshida , who is retiring in June 2016.  ...
Breaking Medicine Technology: